Stryker Corporation vs Bristol-Myers Squibb Company
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Stryker Corporation
$127.2B
์์ #132
Bristol-Myers Squibb Company
$132.0B
์์ #127
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Stryker Corporation์ด(๊ฐ) 2023๋ ๊น์ง Bristol-Myers Squibb Company์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Bristol-Myers Squibb Company์ด(๊ฐ) 2026๋ ๊น์ง Stryker Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Stryker Corporation | Bristol-Myers Squibb Company | ์ ๋ |
|---|---|---|---|
| 2026 | $127.2B | $132.0B | Bristol-Myers Squibb Company |
| 2025 | $134.0B | $107.8B | Stryker Corporation |
| 2024 | $136.1B | $107.6B | Stryker Corporation |
| 2023 | $112.1B | $92.9B | Stryker Corporation |
| 2022 | $90.5B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $97.8B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $88.7B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $75.1B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $55.5B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $54.2B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $41.4B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $31.6B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $31.6B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $24.8B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $17.8B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $15.9B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $16.9B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $15.7B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $12.3B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $22.9B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $16.8B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $13.5B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $14.7B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $12.9B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $10.2B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $8.8B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $7.6B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $5.3B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $4.2B | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $2.8B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $2.2B | $18.8B | Bristol-Myers Squibb Company |
| 1995 | $2.0B | $14.3B | Bristol-Myers Squibb Company |
| 1994 | $1.4B | $9.2B | Bristol-Myers Squibb Company |